Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00936312 · ClinicalTrials.gov registry record
Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study
A clinical trial of Hemophilia A and Hemophilia B, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 200
- Enrollment target
- 11
- Study locations
NCT00936312: Completed study of Hemophilia A and Hemophilia B, sponsored by Weill Medical College of Cornell University.
NCT00936312 is a study of Hemophilia A and Hemophilia B that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 200 participants, above the 87-participant average among 42 other Hemophilia A trials with a reported enrollment target (130% higher). The trial reports 11 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00936312, a study of Hemophilia A and Hemophilia B, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
- 11
- Study locations
Study Summary
This is a multi-center, international study designed to collect clinical, genetic and quality of life information on females with hemophilia, an inherited bleeding disorder. The study is designed to determine whether there are problems and issues unique to females with hemophilia.
Conditions Studied
Study Locations (11)
Other
- Princess Margaret Hospital for Children - Perth
- University Clinic Bonn - Bonn
- University Clinic Munich - Munich
- Sheba Medical Center - Tel Litwinsky
- Instituto G. Gaslini - Genova
- A. Bianchi Bonomi Hemophilia Center - Milan
- Nara Medical University - Nara
- University Hospital Utrecht - Utrecht
- Malmo University Hospital - Malmo
New York
- Weill Cornell Medical College - New York
Changhua
- Changhua Christian Hospital - Chunghua City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2008-03 |
| Est. Completion | 2011-08 |
What the finished NCT00936312 record still lists
NCT00936312 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 87-participant average among 42 other Hemophilia A trials with a reported enrollment target (130% higher).
The record links to 2 conditions, with Hemophilia A appearing as the primary indexed condition, and to 0 interventions.
NCT00936312 lists 11 locations in 3 states (Other, New York, Changhua).
Frequently Asked Questions
What is clinical trial NCT00936312 about?
NCT00936312 is a clinical study titled "Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study". This is a multi-center, international study designed to collect clinical, genetic and quality of life information on females with hemophilia, an inherited bleeding disorder. The study is designed to determine whether there are problems and issues unique to females with hemophilia.
What is the current status of trial NCT00936312?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2008-03. Estimated completion is 2011-08.
What conditions does trial NCT00936312 study?
This clinical trial studies the following conditions: Hemophilia A, Hemophilia B.
Who is sponsoring clinical trial NCT00936312?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00936312 being conducted?
This trial has 11 study locations across New York, Changhua. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemophilia A
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00936312's enrollment target sits among peer trials
200 6th of 42 higher than 36 of 42 other Hemophilia A trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hemophilia A trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
RECRUITING · Phase 3
-
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
RECRUITING · Phase 3
-
A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
RECRUITING · Phase 1
-
Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
RECRUITING · Phase 4
-
Hemophilia A Research Program
RECRUITING
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia